Imperial College London
Portrait Picture

Dr Olivier E. Pardo

Faculty of Medicine, Department of Surgery & Cancer

Reader in Cancer Cell Signalling
 
 
 
//

Contact

 

+44 (0)20 7594 2814o.pardo Website CV

 
 
//

Location

 

145ICTEM buildingHammersmith Campus

//

Summary

 

Publications

Citation

BibTex format

@article{Coombes:2023:10.1038/s41467-023-35969-4,
author = {Coombes, RC and Badman, PD and Lozano-Kuehne, JP and Liu, X and Macpherson, IR and Zubairi, I and Baird, RD and Rosenfeld, N and Garcia-Corbacho, J and Cresti, N and Plummer, R and Armstrong, A and Allerton, R and Landers, D and Nicholas, H and McLellan, L and Lim, A and Mouliere, F and Pardo, OE and Ferguson, V and Seckl, MJ},
doi = {10.1038/s41467-023-35969-4},
journal = {Nature Communications},
pages = {1--1},
title = {Author Correction: Results of the phase IIa RADICAL trial of the FGFR inhibitor AZD4547 in endocrine resistant breast cancer.},
url = {http://dx.doi.org/10.1038/s41467-023-35969-4},
volume = {14},
year = {2023}
}
Download

RIS format (EndNote, RefMan)

TY  - JOUR
AU  - Coombes,RC
AU  - Badman,PD
AU  - Lozano-Kuehne,JP
AU  - Liu,X
AU  - Macpherson,IR
AU  - Zubairi,I
AU  - Baird,RD
AU  - Rosenfeld,N
AU  - Garcia-Corbacho,J
AU  - Cresti,N
AU  - Plummer,R
AU  - Armstrong,A
AU  - Allerton,R
AU  - Landers,D
AU  - Nicholas,H
AU  - McLellan,L
AU  - Lim,A
AU  - Mouliere,F
AU  - Pardo,OE
AU  - Ferguson,V
AU  - Seckl,MJ
DO  - 10.1038/s41467-023-35969-4
EP  - 1
PY  - 2023///
SN  - 2041-1723
SP  - 1
TI  - Author Correction: Results of the phase IIa RADICAL trial of the FGFR inhibitor AZD4547 in endocrine resistant breast cancer.
T2  - Nature Communications
UR  - http://dx.doi.org/10.1038/s41467-023-35969-4
UR  - https://www.ncbi.nlm.nih.gov/pubmed/36650166
UR  - https://www.nature.com/articles/s41467-023-35969-4
UR  - http://hdl.handle.net/10044/1/101967
VL  - 14
ER  -
Download